Wall Street is positive on TG Therapeutics Inc common stock (TGTX). On average, analysts give TG Therapeutics Inc common stock a Strong Buy rating. The average price target is $28.388, which means analysts expect the stock to climb by 7.65% over the next twelve months. That average ranking earns TG Therapeutics Inc common stock an Analyst Rating of 45, which is better than 45% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating TGTX a Strong Buy today. Find out what this means to you and get the rest of the rankings on TGTX!